OBJECTIVE: To evaluate the association between weight variability and disease incidence in women. DESIGN: Prospective cohort study, following women from 1986 through 1992. METHODS: A population-based sample of 33 834 women aged 55±69 y, free of cancer and heart disease, completed a mail-based survey that included self-reported body weights at ages 18, 30, 40, 50 y, and currently. Weight variability was de®ned as (1) the root mean square error around the slope of weight on age (RMSE); and (2) categorical measures of weight change. Outcome measures were incidence of myocardial infarction (MI); stroke; diabetes; breast, endometrial, lung, or other cancer; total and hip fractures. RESULTS: Adjusted relative risks of MI, stroke, diabetes, and hip fracture increased with increasing weight variability. The age and body mass index-adjusted relative risks (RR) for highest vs lowest quartile of RMSE were: MI: 2.03; stroke: 1.61; diabetes: 1.42; breast cancer: 0.85; endomentrial cancer: 0.88; lung cancer: 1.70; other cancer: 0.93; total fractures: 1.15; hip fractures: 1.45. The strongest associations between weight change categories and disease were for diabetes (RR compared to small gain/stable weight: large cycle, 1.72; small cycle, 1.55; large gain, 1.80; weight loss, 1.91; other pattern, 1.55). Large weight cycles were associated with higher risk of MI (RR 1.89) and stroke (RR 1.71). CONCLUSIONS: These ®ndings are consistent with previous studies and suggest that weight variability is associated with higher risk of developing chronic diseases.
Introduction
Prospective epidemiologic studies have established that weight gain, loss, and variability are associated with increased mortality, compared with a stable weight. 1±12 Weight loss may re¯ect underlying illness, thus explaining its link with higher mortality. 4,6,12±14 Weight gain is correlated with changes in risk factors that are associated with increased morbidity and mortality. 15±19 Weight variability that is independent of body mass index level or trend over time may also re¯ect subclinical illness that increases risk of mortality.
1,10±13,20±22
Few studies have examined weight variability in relationship to incident disease. The association between weight variability and incident disease is important to examine as it may provide information on the biological mechanisms linking weight variability to increased mortality. 20±21 For example, increased incidence of hypertension or diabetes may explain links between weight variability and higher cardiovascular disease mortality. Associations between weight variability and incident disease might also provide support for the hypothesis that weight variability re¯ects subclinical disease. Furthermore, since mortality re¯ects both disease incidence and survival, examination of associations between weight variability and incident disease represents a more direct method of approach.
This present study examined weight variability in relationship to incident disease in a large, populationbased cohort of women participating in the Iowa Women's Health Study (IWHS). 23 It was hypothesized that weight variability, weight gain, or weight loss, would be positively associated with incident disease.
Methods

Subjects
The Iowa Women's Health Study is a prospective cohort study of the health risks in older women. 23 The cohort consists of women 55±69 y of age, identi®ed through the 1985 driver's license list for the state of Iowa and who responded to a mailed questionnaire in 1986. Of the 99 826 women originally sampled, 42% (n 41 837) responded. Responders were slightly older, lower in body mass, and were more likely to live in rural counties than nonresponders (see Reference 24 for a detailed comparison of responders vs nonresponders). Follow-up questionnaires were mailed to the respondents at subsequent intervals of 2, 4 and 6 y (in 1988, 1990 and 1992, respectively).
Measures
The initial questionnaire inquired about demographic variables (age, education level, marital status), history of medical conditions (cancer, heart disease, diabetes, hypertension), current and previous smoking behavior, current physical activity (frequency of moderate and heavy-intensity activities), dietary intake (including usual alcohol intake and amount) and hormone replacement status. Waist and hip circumference were measured using a paper tape measure enclosed with the questionnaire. 25 Waist-hip circumference ratio was calculated. Current height and weight, and recalled weights at ages 18, 30, 40 and 50 y were also reported. Body mass index (BMI, kg/m 2 ) was derived from current weight and height.
Weight variability was assessed in two ways. 26, 27 First, the root mean square error (RMSE) deviation around the linear slope of weight in relation to age was calculated for each subject based on self-reported body weight at ages 18, 30, 40, and 50 y. The RMSE re¯ects variability around an individuals's linear slope of weight by age. A second measure of weight variability consisted of categories of body weight change which were also derived from the selfreported weights at each age period. A weight change interval was de®ned as the difference in weight between any two adjacent ages (for example difference between weight at age 30 and weight at age 40 y). A large cycle category included those who gained b 10% of their body weight during one interval and lost b 10% during another interval (regardless of order). A small cycle category included those who gained b 5% but`10% during one interval, and lost between 5 and 10% during another interval (regardless of order). A no change category included those whose weight at baseline differed by`5% from their reported weight at age 18 y, and whose weight change during any interval was`5%. A large gain category included those whose weight either increased or stayed the same during all intervals, and who gained b 10% during at least one interval. A small gain category included those whose weight either increased or stayed the same during all intervals, and who gained between 5±10% during at least one interval. A maintained weight loss category included those who lost b 10% during an interval and who subsequently maintained a weight within AE 5% of that weight value. An other category included those not included in one of the previously de®ned weight categories, including those whose weight change pattern consisted of asymmetric gain and loss cycles (for example a gain of 10% and a loss of 9%).
Cohort follow-up
Information on incident disease between 1986 and 1991 was collected using several methods. , waist-hip ratio, smoking status, pack years of cigarettes, education level, marital status, physical activity, alcohol intake, and hormone replacement therapy (and slope of body weight on age for RMSE analyses). In analyses using weight change categories, small gain and stable weight were combined to increase stability and precision of the relative risk estimates. Furthermore, while conceptually interesting, weight stable is a very unusual lifetime weight change pattern. Small gain was thought to be a more typical weight change pattern and thus appropriate to include in the referent category. Analyses using only the weight stable as the referent category produced relative risks that were generally further from 1.00 and con®dence intervals that were wider. However, the pattern of signi®cance was very familiar to that observed using the combined reference group.
Individuals who reported on the baseline (1986) questionnaire prevalent cancer (n 3 349), heart disease (n 3 625), or both (n 459), or who were missing information on either of these variables (n 570) were excluded from all analyses, leaving an initial eligible n 33 834. Additional exclusions were made for speci®c analyses. Women who reported prevalent prior mastectomy(n 306), hysterectomy (n 10 832), or diabetes (n 1 786) were excluded from analyses of incident breast cancer, endometrial cancer, and diabetes, respectively. Numbers for multivariate analyses varied between 21 715± 31 955 due to missing data and exclusions. Additional sets of strati®ed analyses were run to examine associations in subgroups of interest. In separate fullyadjusted analyses, strati®cation variables were (1) smoking status (never vs always); (2) education level ( high school vs b high school); (3) weight status (body mass index ! 27.3 kg/m 2 vs body mass index`27.3 kg/m 2 ).
Results
Cohort description
The Iowa Women's Health Study cohort was 98% white, 81% had at least a high school education, 76% were currently married, 43% drank alcoholic beverages, 15% currently smoked and 11% reported current hormonal replacement therapy. Table 1 shows demographic and health-related information by quartile of weight variability. Women with more variable weights were heavier, had larger waist-hip ratios, had a greater history of smoking, were less likely to currently drink alcohol, were less physically active, and were less likely to use hormone replacement therapy. They were also less educated, less likely to be currently married, and more likely to report relevant diabetes or hypertension. The majority of women gained weight over time. 1, 23 The prevalence of the various weight change patterns among women free of heart disease and cancer was as follows: Large gain, 33%; small gain, 15%; large cycle, 12%; small cycle, 6%; no change, 3%; weight loss, 5%; other weight pattern, 26%.
Weight variability and incident disease
Weight variability was most strongly associated with higher incidence of myocardial infarction, stroke, and diabetes (Table 2 ). Associations between RMSE and incidence of these diseases persisted after adjustment for BMI, other demographic and health-related variables. The relative risks (RR) for these fully-adjusted models for highest vs lowest quartile of RMSE were: MI 1.73; stroke 1.47; diabetes 1.29. However, after adjustment for women with prevalent diabetes or hypertension, the association between RMSE and stroke was not statistically signi®cant. Weight variability was positively associated with total and hip fracture. After adjustment for confounding variables, the association was no longer signi®cant for total fracture. For hip fracture, a signi®cant linear trend persisted after adjustment, but con®dence intervals for all RMSE quartiles included one. Weight variability was positively associated with lung cancer incidence (RR 1.70) ( Table 2 ). However, after adjustment for demographic and other health-related risk factor variables, this association was not statistically signi®cant. Weight variability was not associated with breast, endometrial, colon or other cancers. In fully adjusted models, associations between weight variability and MI, stroke, and diabetes were similar in overweight and normal weight women, in greater and lesser educated women, and in analysis limited to never smokers. Slope of body weight on age was positively associated with incidence of breast cancer, total fractures, MI and diabetes, and was inversely associated with lung cancer and hip fracture incidence (Table 2) .
Weight change category and incident disease
The strongest associations between weight change categories and incident disease were for MI and diabetes (Table 3 ). Compared to those who had a small gain or were weight stable, all weight change categories had higher relative risks for diabetes. All adjusted RR were signi®cant except for small cycle, and ranged from 1.38±1.94. For MI, unadjusted RRs were signi®cant for large cycles (RR 1.89), large gains (RR 1.35), and weight loss maintenance (RR 1.74). After adjustment for covariates including , age, waist/hip ratio, smoking status (never, former, current), pack years of cigarettes, education (`high school, high school, b high school), physical activity (low, medium, high), alcohol (0,`4, ! g/d), marital status (yes/no), hormone replacement (never, former, current). Model 3: Also adjusted for hypertension (yes/no), and diabetes (yes/no). ** P-value for slope of body weight on age.` ' or`7 ' denotes direction of association. . Reference category is combined group of stable weight (`5% change between ages 18 and 62 y) and small gain (at least one gain between 5 and 10%). Large cycle includes at least one gain b 10% and at least one loss ! 10%. Small cycle includes at least one gain ! 5% but`10% and at least one loss ! 5% but 10%. Large gain includes at least one gain ! 10%. Weight loss maintenance includes a b 10% weight loss with AE 5% maintenance of reduced value. Other includes all other unspeci®ed weight change patterns. diabetes and hypertension, associations were signi®-cant only for large cycles. Associations between weight change categories and stroke were positive, but signi®cant only for large cycles, after adjustment for covariates. Total fractures were not signi®cantly associated with weight change categories. Associations between incidence of hip fracture and weight change categories were positive. Only weight loss maintenance was statistically signi®cant after adjustment. For cancer incidence, large gains were associated with higher relative risks of breast cancer (adjusted RR 1.29). Colon, endometrial and lung cancer were not associated with any weight change category. Results of these analyses were similar when restricted to people who never smoked.
Discussion
The main ®ndings of the present study were that weight variability in women initially free of cancer and heart disease was associated positively with incidence of MI, stroke, and diabetes. Associations were strongest in women with the most variable weights, and generally persisted after adjustment for other demographic and health-related covariates. A categorical measure of weight change also suggested higher incidence of MI, stroke, and diabetes among women who experienced a large weight change. Large cycles were positively associated with diabetes, stroke and MI incidence. Large weight gains were associated positively with breast cancer and diabetes. Weight loss was associated positively with diabetes and hip fracture incidence. Associations were somewhat attenuated with adjustment for health behavior and demographic variables.
These ®ndings are consistent with previous analyses of Iowa Women' Health Study data. French et al 26 found cross-sectional associations between weight variability and several prevalent chronic diseases (MI, heart disease, diabetes) but not cancers. Folsom et al 1 found higher all-cause, total CVD, CHD and non-cancer/non-CVD mortality in women with more variable body weights re¯ected in higher RMSE values. Categorical measures of weight change were associated with all cause mortality and with noncancer/non-CVD mortality, but not with cancer and CVD mortality. Differences between the results of the present study and those reported in previous analyses of the IWHS data are due in part to differences in number of events (a greater number of events increases power for the incidence analyses compared to the available number of events for the mortality analyses). Within-study differences in results using continuous versus categorical measures of weight variability are due in part to properties of the variability measures. Continuous measures, such as the RMSE, have greater power to detect associations because they include the total sample, while speci®c weight change categories may include only a small proportion of the sample and thus have limited power to detect associations with cause-speci®c mortality. 27 The present ®ndings are consistent with several studies that have shown increased incidence of diabetes with weight change (primarily weight gain). Weight gain was associated with increased risk for diabetes in the Nurses Health Study cohort 17 and in another prospective study of health professionals. 18 Rate of weight gain was associated with higher incidence of diabetes in a cohort of Pima Indians. 19 In another study, weight variability (coef®cient of variation: CV) was associated positively with incident diabetes in Swedish women but not in men. 10 However, Hanson 19 found no association between weight variability as re¯ected in the RMSE and diabetes incidence in Pimas. Weight loss was associated with decreased risk of diabetes in another study. 29 Other studies have found associations between weight gain and increases in risk factors such as blood pressure, serum cholesterol and fasting blood glucose. 15, 16, 22 The ®ndings on weight variability and incidence of heart disease have been less consistent. Weight gain was associated with higher incidence of heart disease in several studies, 5, 16, 30 including the Nurses Health Study. 30 Weight loss also has been associated with higher heart disease incidence in normal weight or thinner people. 5, 31 Weight variability as measured by the CV, however, was not related to heart disease incidence in two studies. 10, 22 Weight change in older years has been associated with risk of hip fracture in previous studies. In a prospective study of 3683 white women age 50 y or older, weight gain of b 10% was protective for hip fracture, while weight loss of b 10% increased risk. 32 Similar associations were found in a study of 9516 white women aged 65 y or older. 33 In both studies, recent weight change was associated with risk independent of current BMI. In the present study, weight variability as measured by RMSE was associated positively with hip fracture incidence. Slope of weight change on age was independently and inversely associated with incidence of hip fracture. Weight loss maintenance was associated with greater incidence of hip fracture.
The biological mechanisms underlying the associations between weight variability and incident disease are not yet clearly understood. Weight gain or weight cycling may increase risk of heart disease, stroke or diabetes by directly accelerating atherosclerosis, or by acting through cardiovascular disease risk factors such as blood pressure, cholesterol, or blood glucose levels. 15±22,29,31 Weight gain may reduce risk of fracture through greater adipose-based estrogen production and greater gravitational forces on the bones. 32, 33 Weight gain might also reduce physical mobility and thereby decrease risk of falls that may contribute to hip fractures. Weight loss might increase risk of fracture through similar mechanisms (namely low-ering estrogen levels and decreased bone mineral density, which is a risk factor for hip fractures). Weight loss may also increase risk of falls through reduced lower extremity strength which may accompany weight loss. 32±35 Associations between large weight gains and breast cancer found in the present study and in previous studies may be mediated by estrogen levels or bioavailability. 36 Weight gain may stimulate estrogen production or increase levels of insulin or growth factors and thus promote tumor growth. 36 Clearly, further research designed to test speci®c hypotheses regarding the mechanisms by which weight changes increase or lower risk of speci®c chronic diseases is needed.
A methodological limitation in the present study as well as other studies which examine associations between weight variability and disease is the imprecision of the available measures of weight variability. 27 Two widely used measures of weight variability, the RMSE and the CV, do not distinguish directionality of weight changes. Thus, a given RMSE or CV value may re¯ect a large gain, a large loss, or a weight cycle (gain-loss). A further limitation of these measures is the lack of information on reasons for the weight changes. Weight changes may be unintentional, and thus perhaps due to underlying illness. Alternatively, weight changes may be intentional, re¯ecting weight loss efforts for health or cosmetic reasons. Moreover, weight changes are confounded with weight level itself, as well as by other risk factors. Statistical adjustment probably reduces but does not eliminate the confounding effects of these variables. In the Iowa Women's Health Study, unintentional weight loss was associated with higher prevalent disease and poorer self-perceived health. 26 Whether or not the reason for the weight loss is related to health outcomes prospectively is an issue in need of additional research.
Other study limitations include the use of selfreported body weights and incident MI, stroke, diabetes, and fracture. Self-reported body weight has been shown to be accurate, however. 37, 38 Self-reported diabetes and cardiovascular disease are also reasonably accurate, although generally under-reported.
39±42
In addition, the cohort included only women who survived to middle to older ages. Finally, only small numbers were available for endpoints for some of the categories of weight change, thus limiting power to detect associations (for example for hip fracture, endometrial and lung cancer). Study strengths include the size of the sample, its population-based design and its full spectrum of body weight.
Weight variability, whether it is weight gain, weight loss, or a pattern of gain and loss, is associated with higher incidence of several chronic diseases. The biological mechanisms for these associations have not been established and probably differ for speci®c diseases. Weight variability may also re¯ect preexisting disease or poor health, thus explaining its link with disease incidence. Further research is needed to clarify the mechanisms relating weight variability to chronic disease incidence.
